Format

Send to:

Choose Destination
See comment in PubMed Commons below
Breast Cancer Res. 2007;9(3):107.

Estrogen receptor-beta: why may it influence clinical outcome in estrogen receptor-alpha positive breast cancer?

Abstract

In the previous issue of the journal, Lin and coworkers present data demonstrate that increased expression of estrogen receptor (ER)-beta in ER-alpha-positive breast cancer cells antagonizes a defined group of ER-alpha/estrogen stimulated genes that are involved in cell cycle regulation and DNA replication. Similar expression patterns for these genes were found human ER-alpha positive breast tumors expressing higher levels or ER-beta, and this correlated with better clinical outcome. The implications for these data, which suggest that ER-beta is a positive actor and diagnostic marker for therapeutic outcome, are discussed.

PMID:
17617929
[PubMed - indexed for MEDLINE]
PMCID:
PMC1929104
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk